Sector: MedicalPenwest Pharmaceuticals Co. (NASDAQ: PPCO)
Ranking History
Scan Date: | 10/27/2009 |
Sector: | Medical |
Funamental : | 187 |
Technical : | 134 |
Performance : | 294 |
Overall: | 253 |
Number of Stocks: | 306 |
Scan Date: | 10/20/2009 |
Sector: | Medical |
Funamental : | 189 |
Technical : | 299 |
Performance : | 292 |
Overall: | 301 |
Number of Stocks: | 305 |
Scan Date: | 10/15/2009 |
Sector: | Medical |
Funamental : | 190 |
Technical : | 301 |
Performance : | 291 |
Overall: | 301 |
Number of Stocks: | 305 |
Headlines
- Penwest Reports Third Quarter 2009 Financial Results
Nov 05, 2009 08:04 AM | PPCO
- Penwest Third Quarter 2009 Financial Results Conference Call
Oct 30, 2009 01:47 PM | PPCO
- Penwest Formulation Demonstrates Proof-of-Principal in Phase I Trial in Development Program With Otsuka Pharmaceutical
Oct 28, 2009 08:03 AM | PPCO
- Synergy Pharmaceuticals Announces Appointment of Dr. Alan F. Joslyn to Board of Directors
Oct 08, 2009 08:30 AM | JNJ, PPCO
- Penwest Named One of Connecticut's Fastest Growing Technology Companies
Oct 08, 2009 08:02 AM | PPCO
- Penwest to Present At Thomas Weisel Partners 2009 Healthcare Conference
Sep 03, 2009 09:02 AM | PPCO
- Penwest Shareholders Want Liquidation
Mar 04, 2009 01:10 PM | ENDP, MYL, PPCO
- Penwest Shareholders Demand Change
Jan 12, 2009 11:16 AM | ANDW, MYL, PPCO
- Quiet Day
Jun 11, 2008 11:56 AM | AAUK, ABPI, AGU, ALVR, ANAD, BIIB
- This Week's Insider Buys - Apr 6 2008 1:39PM
Apr 06, 2008 01:39 PM | CHDN, COMS, CORT, CVO, ESC, HERO
- Penwest Reports Second Quarter 2009 Financial Results
Aug 07, 2009 08:01 AM | PPCO
- Penwest Second Quarter 2009 Financial Results Conference Call
Jul 29, 2009 04:16 PM | PPCO
- Penwest Announces Results of Phase Ib Trial of A0001
Jul 16, 2009 08:00 AM | PPCO
- Penwest Announces That the Results of Its Annual Meeting Have Been Certified
Jun 24, 2009 04:30 PM | PPCO
- Penwest Enters Into Third Research and Development Agreement With Otsuka Pharmaceutical
Jun 17, 2009 09:53 AM | PPCO
- Shareholders Elect Tang Capital and Perceptive Nominees and Approve Shareholder Resolution
Jun 10, 2009 03:09 PM | PPCO
- Penwest Announces Preliminary Vote Count At Annual Meeting
Jun 10, 2009 01:42 PM | PPCO
- Penwest Urges Shareholders to Vote the White Proxy Card Today and Reject Dissident Proposals and Nominees At Wednesday's Annual Meeting
Jun 09, 2009 10:01 AM | PPCO
- Penwest and Endo Grant Valeant Pharmaceuticals Exclusive License to Market Opana(R) ER in Canada, Australia and New Zealand; Agreement Demonstrates Value of OPANA ER in Markets Outside U.S.
Jun 09, 2009 08:02 AM | NVS, PPCO, VRX
- Penwest and Endo Grant Valeant Pharmaceuticals Exclusive License to Market Opana(r) ER in Canada, Australia and New Zealand
Jun 09, 2009 07:31 AM | ENDP, PPCO, VRX
- Form 4 DRAKE PETER F For: Oct 01 (10K)
Oct 05, 2009 02:18 PM
- Form 4 FREIMAN PAUL E For: Sep 03 (10K)
Sep 16, 2009 05:35 PM
- Form 4 DRAKE PETER F For: Jul 01 (10K)
Jul 02, 2009 01:02 PM
- Form 4 DRAKE PETER F For: Apr 13 (10K)
Apr 20, 2009 02:57 PM
- Form 4 DRAKE PETER F For: Apr 01 (10K)
Apr 03, 2009 05:24 PM
- Form 4 PENWEST PHARMACEUTICALS For: Mar 11 Filed by: PERCEPTIVE ADVISORS LLC (10K)
Mar 31, 2009 04:38 PM
- Form 4 TANG KEVIN C For: Mar 11 (10K)
Mar 13, 2009 08:42 PM
- Form 4 TANG KEVIN C For: Mar 06 (10K)
Mar 10, 2009 06:32 PM
- Form 4 TANG KEVIN C For: Mar 05 (10K)
Mar 09, 2009 07:25 PM
- Form 4 PENWEST PHARMACEUTICALS For: Mar 06 Filed by: PERCEPTIVE ADVISORS LLC (10K)
Mar 09, 2009 06:32 PM
Analyst Ratings
Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
Share Performance
|
Period
|
PPCO
|
Compare to S&P
|
| YTD |
37.58 %
|
19.93 %
|
| 4 Weeks |
9.64 %
|
8.48 %
|
| 12 Weeks |
-23.13 %
|
-25.04 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: -133.33 %
|
|
EPS Growth in Last Year: 68.18 %
|
|
Sales Growth in Last Quarter: -0.21 %
|
|
Sales Growth in Last Quarter: 299.62 %
|
|
